Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.32 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.31 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.31 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.30 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL4893242 | 0.97 | KMT2A (0.37) | TSHRMEN1GAAKMT2ACAMK2A | |
| SCHEMBL30037733 | 0.96 | TSHR (0.38) | TSHRMEN1GAAKMT2ASLC22A6 | |
| Ethylene Glycol SCHEMBL4908864 | 0.91 | PSMB8 (0.31) | MEN1GAAKMT2APSMB8PSMB5 | |
| Ethylene Glycol SCHEMBL6129445 | 0.90 | TSHR (0.40) | TSHRMEN1GAAKMT2ACAMK2A | |
| Urea SCHEMBL4905652 | 0.85 | TSHR (0.37) | TSHRMEN1GAAKMT2ACAMK2A | |
| Ethylene Glycol SCHEMBL28881509 | 0.85 | GPR84 (0.42) | TSHRMEN1GAAKMT2ACAMK2A | |
| Ethylene Glycol SCHEMBL28342229 | 0.85 | GPR84 (0.42) | TSHRMEN1GAAKMT2ACAMK2A | |
| SCHEMBL28353477 | 0.85 | SMN1; SMN2 (0.38) | MEN1GAAKMT2A | |
| SCHEMBL34382 | 0.85 | TSHR (0.44) | TSHRMEN1GAAKMT2ACAMK2A | |
| SCHEMBL4902271 | 0.84 | MGLL (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4331635-A1 | METHOD FOR MANUFACTURING ADHESION-PREVENTING FILM | Mepion Co., Ltd. (KR) | 2024-03-06 | — | — | EP | claimed |
| US-20240033032-A1 | METHOD FOR MANUFACTURING ADHESION-PREVENTING FILM | MEPION CO., LTD. (KR) | 2024-02-01 | — | — | US | claimed |
| US-20080159975-A1 | Hair treatment composition, hair treatment agent and method for treating hair by using the same | SUNBIO, INC. (KR) | 2008-07-03 | — | — | US | claimed |
| EP-1938795-A2 | Hair treatment composition, hair treatment agent and method for treating hair by using the same | Sunbio, Inc. (KR) | 2008-07-02 | — | — | EP | claimed |
| EP-4331635-A1 | METHOD FOR MANUFACTURING ADHESION-PREVENTING FILM | Mepion Co., Ltd. (KR) | 2024-03-06 | — | — | EP | disclosed |
| US-20240033032-A1 | METHOD FOR MANUFACTURING ADHESION-PREVENTING FILM | MEPION CO., LTD. (KR) | 2024-02-01 | — | — | US | disclosed |
| CN-117157113-A | Method for producing anti-blocking film | 株式会社迈碧温 | 2023-12-01 | — | — | CN | disclosed |
| US-20080159975-A1 | Hair treatment composition, hair treatment agent and method for treating hair by using the same | SUNBIO, INC. (KR) | 2008-07-03 | — | — | US | disclosed |
| EP-1938795-A2 | Hair treatment composition, hair treatment agent and method for treating hair by using the same | Sunbio, Inc. (KR) | 2008-07-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080159975-A1 | Hair treatment composition, hair treatment agent and method for treating hair by using the same | KRT18, CUTA, KRTCAP2 | TSHR 3358/4885MEN1 3319/4885GAA 4019/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.